查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423186

2024-2032年按治療類型（皮下免疫療法、舌下免疫療法）、過敏類型、配銷通路和地區分類的過敏免疫療法市場報告

Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ), Allergy Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2023年全球過敏免疫療法市場規模達31億美元。展望未來， IMARC Group預計到2032年市場規模將達到67億美元，2024-2032年複合年成長率（CAGR）為8.7%。

過敏免疫治療，也稱為脫敏或低敏治療，是針對過敏原（包括各種食物、藥物、蜂毒、草花粉和屋塵蟎）的過敏反應的預防性醫學治療。它透過逐漸增加過敏原的劑量來改變免疫系統的反應。在治療開始之前，過敏症專家和患者會分析過敏症狀的觸發因素，其中可能涉及皮膚和血液檢查以確認過敏原。過敏免疫療法有助於減少發炎、提供長期影響、提高免疫耐受性、改變病程並改善患者的生活品質。

近年來，由於影響免疫系統功能的各種環境和生活方式因素，世界各地過敏的盛行率有所上升。隨著人們對過敏免疫療法的認知不斷增強、收入水平的提高和醫療保健支出的增加，對複雜和長期治療方案的需求不斷增加，這反過來又刺激了市場的成長。由於世界各地政府和非政府組織採取的多項舉措，臨床研究和開發預算不斷增加，進一步支持了這一點。此外，利用最新的藥物開發技術，製藥公司已經創造了更有效的免疫療法，可以成功治療一系列過敏。再加上過敏診斷領域的進步，正在促進全球過敏免疫療法市場的成長。

本報告回答的關鍵問題

  • 2023年全球過敏免疫療法市場規模有多大？
  • 2024-2032年全球過敏免疫治療市場的預期成長率是多少？
  • 推動全球過敏免疫治療市場的關鍵因素是什麼？
  • COVID-19 對全球過敏免疫療法市場有何影響？
  • 根據治療類型，全球過敏免疫療法市場的細分如何？
  • 根據過敏類型，全球過敏免疫治療市場的細分如何？
  • 基於配銷通路的全球過敏免疫治療市場的詳細情形如何？
  • 全球過敏免疫治療市場的關鍵地區有哪些？
  • 誰是全球過敏免疫治療市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球過敏免疫療法市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：按治療類型
  • 市場區隔：依過敏類型
  • 市場區隔：按配銷通路
  • 市場區隔：按地區
  • 市場預測

第 6 章：市場區隔：依治療類型

  • 皮下免疫療法（SCIT）
    • 市場走向
    • 市場預測
  • 舌下免疫療法（SLIT）
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依過敏類型

  • 過敏性鼻炎
    • 市場走向
    • 市場預測
  • 氣喘
    • 市場走向
    • 市場預測
  • 食物過敏
    • 市場走向
    • 市場預測
  • 毒液過敏
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥房
    • 市場走向
    • 市場預測
  • 網路藥房
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 歐洲
    • 市場走向
    • 市場預測
  • 北美洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Stallergenes Greer
    • HAL Allergy Holding BV
    • DBV Technologies
    • Merck KGaA
    • Aimmune Therapeutics
    • Circassia Pharmaceuticals
    • Anergis SA
    • Biomay AG
Product Code: SR112024A1401

Abstract

The global allergy immunotherapies market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.7% during 2024-2032.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on treatment type, allergy type and distribution channel.

Breakup by Treatment Type:

Subcutaneous Immunotherapy (SCIT)

Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

Allergic Rhinitis

Asthma

Food Allergy

Venom Allergy

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

Europe

North America

Asia Pacific

Middle East and Africa

Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Key Questions Answered in This Report

  • 1. What was the size of the global allergy immunotherapies market in 2023?
  • 2. What is the expected growth rate of the global allergy immunotherapies market during 2024-2032?
  • 3. What are the key factors driving the global allergy immunotherapies market?
  • 4. What has been the impact of COVID-19 on the global allergy immunotherapies market?
  • 5. What is the breakup of the global allergy immunotherapies market based on the treatment type?
  • 6. What is the breakup of the global allergy immunotherapies market based on the allergy type?
  • 7. What is the breakup of the global allergy immunotherapies market based on the distribution channel?
  • 8. What are the key regions in the global allergy immunotherapies market?
  • 9. Who are the key players/companies in the global allergy immunotherapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Treatment Type
  • 5.5 Market Breakup by Allergy Type
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Subcutaneous Immunotherapy (SCIT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sublingual Immunotherapy (SLIT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Allergy Type

  • 7.1 Allergic Rhinitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Food Allergy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Venom Allergy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Europe
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 North America
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ALK-Abello A/S
    • 14.3.2 Allergy Therapeutics
    • 14.3.3 Stallergenes Greer
    • 14.3.4 HAL Allergy Holding B.V.
    • 14.3.5 DBV Technologies
    • 14.3.6 Merck KGaA
    • 14.3.7 Aimmune Therapeutics
    • 14.3.8 Circassia Pharmaceuticals
    • 14.3.9 Anergis SA
    • 14.3.10 Biomay AG

List of Figures

  • Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
  • Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2023
  • Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2023
  • Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
  • Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
  • Figure 10: Global: Allergy Immunotherapies Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2018 & 2023
  • Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2024-2032
  • Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2018 & 2023
  • Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2024-2032
  • Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2018 & 2023
  • Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2024-2032
  • Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2024-2032
  • Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Allergy Immunotherapies Market Structure
  • Table 7: Global: Allergy Immunotherapies Market: Key Players